Atumnus LLC
Founding institutional entity behind endogenicpharmacology.com. Holds the proprietary technology base u2014 the trade-named bioregulator portfolio (Telogenixu2122, Thymogenixu2122, Vasogenixu2122, Dermogenixu2122, Cortigenixu2122, Lymphogenixu2122, and Gonadogenixu2122), a patent-pending IP estate, and the institutional research and licensing infrastructure. The canonical reference at this site is published by Atumnus LLC